FOXO3 and colorectal cancer: Of note, in colorectal cancer cells, signaling via p38MAPK represses FOXO3a activity and inhibition of p38MAPK has been shown to increase the effect of cisplatin by inducing FOXO3a dephosphorylation (Germani et al., 2014).